BindingDB logo
myBDB logout

BDBM50234041 CHEMBL4060679::US9765018, Example 116

SMILES: COc1ccc(cc1C(O)=O)-c1ccc(Oc2cccc3CCCCc23)c(NC(=O)Nc2cccc(C)c2)c1

InChI Key: InChIKey=SSUQEFNUCUXHQL-UHFFFAOYSA-N

Data: 10 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 10 hits for monomerid = 50234041   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Cytochrome P450 2C19


(Homo sapiens (Human))
BDBM50234041
PNG
(CHEMBL4060679 | US9765018, Example 116)
Show SMILES COc1ccc(cc1C(O)=O)-c1ccc(Oc2cccc3CCCCc23)c(NC(=O)Nc2cccc(C)c2)c1
Show InChI InChI=1S/C32H30N2O5/c1-20-7-5-10-24(17-20)33-32(37)34-27-19-23(22-13-15-28(38-2)26(18-22)31(35)36)14-16-30(27)39-29-12-6-9-21-8-3-4-11-25(21)29/h5-7,9-10,12-19H,3-4,8,11H2,1-2H3,(H,35,36)(H2,33,34,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
n/an/a>3.00E+3n/an/an/an/an/an/a



Bristol-Myers Squibb Research and Development

Curated by ChEMBL


Assay Description
Inhibition of CYP2C19 (unknown origin)


Bioorg Med Chem Lett 27: 582-585 (2017)


BindingDB Entry DOI: 10.7270/Q2QN6914
More data for this
Ligand-Target Pair
Cytochrome P450 2D6


(Homo sapiens (Human))
BDBM50234041
PNG
(CHEMBL4060679 | US9765018, Example 116)
Show SMILES COc1ccc(cc1C(O)=O)-c1ccc(Oc2cccc3CCCCc23)c(NC(=O)Nc2cccc(C)c2)c1
Show InChI InChI=1S/C32H30N2O5/c1-20-7-5-10-24(17-20)33-32(37)34-27-19-23(22-13-15-28(38-2)26(18-22)31(35)36)14-16-30(27)39-29-12-6-9-21-8-3-4-11-25(21)29/h5-7,9-10,12-19H,3-4,8,11H2,1-2H3,(H,35,36)(H2,33,34,37)
PDB

UniProtKB/SwissProt
UniProtKB/TrEMBL

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
n/an/a>3.00E+3n/an/an/an/an/an/a



Bristol-Myers Squibb Research and Development

Curated by ChEMBL


Assay Description
Inhibition of CYP2D6 (unknown origin)


Bioorg Med Chem Lett 27: 582-585 (2017)


BindingDB Entry DOI: 10.7270/Q2QN6914
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))
BDBM50234041
PNG
(CHEMBL4060679 | US9765018, Example 116)
Show SMILES COc1ccc(cc1C(O)=O)-c1ccc(Oc2cccc3CCCCc23)c(NC(=O)Nc2cccc(C)c2)c1
Show InChI InChI=1S/C32H30N2O5/c1-20-7-5-10-24(17-20)33-32(37)34-27-19-23(22-13-15-28(38-2)26(18-22)31(35)36)14-16-30(27)39-29-12-6-9-21-8-3-4-11-25(21)29/h5-7,9-10,12-19H,3-4,8,11H2,1-2H3,(H,35,36)(H2,33,34,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
n/an/a>3.00E+3n/an/an/an/an/an/a



Bristol-Myers Squibb Research and Development

Curated by ChEMBL


Assay Description
Inhibition of CYP3A4 (unknown origin) using BFC as substrate


Bioorg Med Chem Lett 27: 582-585 (2017)


BindingDB Entry DOI: 10.7270/Q2QN6914
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))
BDBM50234041
PNG
(CHEMBL4060679 | US9765018, Example 116)
Show SMILES COc1ccc(cc1C(O)=O)-c1ccc(Oc2cccc3CCCCc23)c(NC(=O)Nc2cccc(C)c2)c1
Show InChI InChI=1S/C32H30N2O5/c1-20-7-5-10-24(17-20)33-32(37)34-27-19-23(22-13-15-28(38-2)26(18-22)31(35)36)14-16-30(27)39-29-12-6-9-21-8-3-4-11-25(21)29/h5-7,9-10,12-19H,3-4,8,11H2,1-2H3,(H,35,36)(H2,33,34,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
n/an/a>3.00E+3n/an/an/an/an/an/a



Bristol-Myers Squibb Research and Development

Curated by ChEMBL


Assay Description
Inhibition of CYP3A4 (unknown origin) using BZR as substrate


Bioorg Med Chem Lett 27: 582-585 (2017)


BindingDB Entry DOI: 10.7270/Q2QN6914
More data for this
Ligand-Target Pair
Indoleamine 2,3-dioxygenase


(Homo sapiens (Human))
BDBM50234041
PNG
(CHEMBL4060679 | US9765018, Example 116)
Show SMILES COc1ccc(cc1C(O)=O)-c1ccc(Oc2cccc3CCCCc23)c(NC(=O)Nc2cccc(C)c2)c1
Show InChI InChI=1S/C32H30N2O5/c1-20-7-5-10-24(17-20)33-32(37)34-27-19-23(22-13-15-28(38-2)26(18-22)31(35)36)14-16-30(27)39-29-12-6-9-21-8-3-4-11-25(21)29/h5-7,9-10,12-19H,3-4,8,11H2,1-2H3,(H,35,36)(H2,33,34,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
US Patent
n/an/a 790n/an/an/an/an/an/a



Bristol-Myers Squibb Company; Syngene International Limited; Bristol-Myers Squibb Company

US Patent


Assay Description
Human IDO1/HEK293 cells were seeded at 10,000 cells per 50 uL per well with RPMI/phenol red free media contains 10% FBS in a 384-well black wall clea...


US Patent US9765018 (2017)


BindingDB Entry DOI: 10.7270/Q2KP849H
More data for this
Ligand-Target Pair
Cytochrome P450 2B6


(Homo sapiens (Human))
BDBM50234041
PNG
(CHEMBL4060679 | US9765018, Example 116)
Show SMILES COc1ccc(cc1C(O)=O)-c1ccc(Oc2cccc3CCCCc23)c(NC(=O)Nc2cccc(C)c2)c1
Show InChI InChI=1S/C32H30N2O5/c1-20-7-5-10-24(17-20)33-32(37)34-27-19-23(22-13-15-28(38-2)26(18-22)31(35)36)14-16-30(27)39-29-12-6-9-21-8-3-4-11-25(21)29/h5-7,9-10,12-19H,3-4,8,11H2,1-2H3,(H,35,36)(H2,33,34,37)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
n/an/a>3.00E+3n/an/an/an/an/an/a



Bristol-Myers Squibb Research and Development

Curated by ChEMBL


Assay Description
Inhibition of CYP2B6 (unknown origin)


Bioorg Med Chem Lett 27: 582-585 (2017)


BindingDB Entry DOI: 10.7270/Q2QN6914
More data for this
Ligand-Target Pair
Indoleamine 2,3-dioxygenase


(Homo sapiens (Human))
BDBM50234041
PNG
(CHEMBL4060679 | US9765018, Example 116)
Show SMILES COc1ccc(cc1C(O)=O)-c1ccc(Oc2cccc3CCCCc23)c(NC(=O)Nc2cccc(C)c2)c1
Show InChI InChI=1S/C32H30N2O5/c1-20-7-5-10-24(17-20)33-32(37)34-27-19-23(22-13-15-28(38-2)26(18-22)31(35)36)14-16-30(27)39-29-12-6-9-21-8-3-4-11-25(21)29/h5-7,9-10,12-19H,3-4,8,11H2,1-2H3,(H,35,36)(H2,33,34,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
n/an/a 100n/an/an/an/an/an/a



Bristol-Myers Squibb Research and Development

Curated by ChEMBL


Assay Description
Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells assessed as inhibition of kynurenine production preincubated with cells followed by IFN-g...


Bioorg Med Chem Lett 27: 582-585 (2017)


BindingDB Entry DOI: 10.7270/Q2QN6914
More data for this
Ligand-Target Pair
Cytochrome P450 2C9


(Homo sapiens (Human))
BDBM50234041
PNG
(CHEMBL4060679 | US9765018, Example 116)
Show SMILES COc1ccc(cc1C(O)=O)-c1ccc(Oc2cccc3CCCCc23)c(NC(=O)Nc2cccc(C)c2)c1
Show InChI InChI=1S/C32H30N2O5/c1-20-7-5-10-24(17-20)33-32(37)34-27-19-23(22-13-15-28(38-2)26(18-22)31(35)36)14-16-30(27)39-29-12-6-9-21-8-3-4-11-25(21)29/h5-7,9-10,12-19H,3-4,8,11H2,1-2H3,(H,35,36)(H2,33,34,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
n/an/a>3.00E+3n/an/an/an/an/an/a



Bristol-Myers Squibb Research and Development

Curated by ChEMBL


Assay Description
Inhibition of CYP2C9 (unknown origin)


Bioorg Med Chem Lett 27: 582-585 (2017)


BindingDB Entry DOI: 10.7270/Q2QN6914
More data for this
Ligand-Target Pair
Cytochrome P450 1A2


(Homo sapiens (Human))
BDBM50234041
PNG
(CHEMBL4060679 | US9765018, Example 116)
Show SMILES COc1ccc(cc1C(O)=O)-c1ccc(Oc2cccc3CCCCc23)c(NC(=O)Nc2cccc(C)c2)c1
Show InChI InChI=1S/C32H30N2O5/c1-20-7-5-10-24(17-20)33-32(37)34-27-19-23(22-13-15-28(38-2)26(18-22)31(35)36)14-16-30(27)39-29-12-6-9-21-8-3-4-11-25(21)29/h5-7,9-10,12-19H,3-4,8,11H2,1-2H3,(H,35,36)(H2,33,34,37)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
n/an/a>3.00E+3n/an/an/an/an/an/a



Bristol-Myers Squibb Research and Development

Curated by ChEMBL


Assay Description
Inhibition of CYP1A2 (unknown origin)


Bioorg Med Chem Lett 27: 582-585 (2017)


BindingDB Entry DOI: 10.7270/Q2QN6914
More data for this
Ligand-Target Pair
Cytochrome P450 2C8


(Homo sapiens (Human))
BDBM50234041
PNG
(CHEMBL4060679 | US9765018, Example 116)
Show SMILES COc1ccc(cc1C(O)=O)-c1ccc(Oc2cccc3CCCCc23)c(NC(=O)Nc2cccc(C)c2)c1
Show InChI InChI=1S/C32H30N2O5/c1-20-7-5-10-24(17-20)33-32(37)34-27-19-23(22-13-15-28(38-2)26(18-22)31(35)36)14-16-30(27)39-29-12-6-9-21-8-3-4-11-25(21)29/h5-7,9-10,12-19H,3-4,8,11H2,1-2H3,(H,35,36)(H2,33,34,37)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
PubMed
n/an/a>3.00E+3n/an/an/an/an/an/a



Bristol-Myers Squibb Research and Development

Curated by ChEMBL


Assay Description
Inhibition of CYP2C8 (unknown origin)


Bioorg Med Chem Lett 27: 582-585 (2017)


BindingDB Entry DOI: 10.7270/Q2QN6914
More data for this
Ligand-Target Pair